Last reviewed · How we verify
NCT05926479
Validation And Turkish Cross-Cultural Adaptation of Treatment Expectation Questionnaire (TEX-Q) Tool
trial testing Translating the Questionnaire into Turkish and Related Processes in Physiotherapy Patients in 150 participants. Completed in 1 September 2023.
1 September 2023
Quick facts
| Lead sponsor | Istanbul Bilgi University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 150 |
| Start date | 21 June 2023 |
| Primary completion | 1 September 2023 |
| Estimated completion | 1 September 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Translating the Questionnaire into Turkish and Related Processes
- Validity
- Reliability
Conditions studied
- Physiotherapy Patients — all drugs for Physiotherapy Patients →
Sponsor
Istanbul Bilgi University
Who can join
Adults 18 to 65, any sex, with Physiotherapy Patients. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The general treatment expectations of patients play a significant role in determining the outcomes of the different treatments they undergo. When it comes to physiotherapy programs, these expectations act as non-specific treatment components, capable of triggering subjective psychological changes and eliciting mechanisms that resemble placebo effects. When theory-based, multidimensional measurement tools that evaluate patients' expectations from various treatments are examined, the Treatment Expectation Questionnaire (TEX-Q) questionnaire stands out. The aim of this study is to ensure the validity and reliability of the Turkish version of this form, which can be answered by every patient receiving various treatments, as an objective alternative and to be included among other treatment expectancy measurement tools.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05926479
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Translating the Questionnaire into Turkish and Related Processes
Trials testing the same drug.
- NCT07107412 — Turkish General Rehabilitation Adherence Scale in Osteoarthritis Patients · completed
- NCT06297733 — Turkish Adaptation, Validity and Reliability of the Approaches and Study Skills Inventory in Physiotherapy Students · completed
- NCT04222036 — Validity and Reliability of the Expectation Scale in the Treatment of Chronic Pain · unknown
Other Istanbul Bilgi University trials
Trials by the same sponsor.
- NCT06800144 — Effect of Music Therapy on Pain in People With Multiple Sclerosis · NA · recruiting
- NCT06847763 — The Long Term Effects of Online Therapeutic Neuroscience Education in Patients With Chronic Low Back Pain · NA · recruiting
- NCT07293624 — Effects of the Dietary Inflammatory Index on Systemic Inflammation Markers and Gastrointestinal Symptoms in Individuals · enrolling by invitation
- NCT07004478 — Turkish Adaptation Study of the Generic Functional Index · recruiting
- NCT07114341 — Effect of Lyophilized Cornelian Cherry on Anaerobic Performance in Young Football Players · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05926479 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Istanbul Bilgi University
- Last refreshed: 28 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05926479.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing